134 related articles for article (PubMed ID: 23764680)
1. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
2. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
[TBL] [Abstract][Full Text] [Related]
3. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
4. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
[TBL] [Abstract][Full Text] [Related]
5. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
6. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
[TBL] [Abstract][Full Text] [Related]
7. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
8. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
[TBL] [Abstract][Full Text] [Related]
9. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
10. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
[TBL] [Abstract][Full Text] [Related]
11. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
12. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: a Scottish experience.
Mukherjee A; Morton S; Fraser S; Salmond J; Baxter G; Leung HY
Scott Med J; 2014 Nov; 59(4):204-8. PubMed ID: 25314954
[TBL] [Abstract][Full Text] [Related]
14. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
Gershman B; Zietman AL; Feldman AS; McDougal WS
Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
[TBL] [Abstract][Full Text] [Related]
15. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
Merrick GS; Gutman S; Andreini H; Taubenslag W; Lindert DL; Curtis R; Adamovich E; Anderson R; Allen Z; Butler W; Wallner K
Eur Urol; 2007 Sep; 52(3):715-23. PubMed ID: 17337114
[TBL] [Abstract][Full Text] [Related]
17. Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.
Zhang Q; Wang W; Yang R; Zhang G; Zhang B; Li W; Huang H; Guo H
Int Urol Nephrol; 2015 May; 47(5):727-33. PubMed ID: 25820744
[TBL] [Abstract][Full Text] [Related]
18. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
19. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract][Full Text] [Related]
20. The morbidity of transperineal template-guided prostate mapping biopsy.
Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
